Article thumbnail

Role of Caveolae in Cardiac Protection

By David M. Roth and Hemal H. Patel

Abstract

Myocardial ischemia/reperfusion injury is a major cause of morbidity and mortality. The molecular signaling pathways involved in cardiac protection from myocardial ischemia/reperfusion injury are complex. An emerging idea in signal transduction suggests the existence of spatially organized complexes of signaling molecules in lipid-rich microdomains of the plasma membrane known as caveolae. Caveolins—proteins abundant in caveolae—provide a scaffold to organize, traffic, and regulate signaling molecules. Numerous signaling molecules involved in cardiac protection are known to exist within caveolae or interact directly with caveolins. Over the last 4 years, our laboratories have explored the hypothesis that caveolae are vitally important to cardiac protection from myocardial ischemia/reperfusion injury. We have provided evidence that (1) caveolae and the caveolin isoforms 1 and 3 are essential for cardiac protection from myocardial ischemia/reperfusion injury, (2) stimuli that produce preconditioning of cardiac myocytes, including brief periods of ischemia/reperfusion and exposure to volatile anesthetics, alter the number of membrane caveolae, and (3) cardiac myocyte-specific overexpression of caveolin-3 can produce innate cardiac protection from myocardial ischemia/reperfusion injury. The work demonstrates that caveolae and caveolins are critical elements of signaling pathways involved in cardiac protection and suggests that caveolins are unique targets for therapy in patients at risk of myocardial ischemia

Topics: Riley Symposium
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:3051068
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1993). Calcium pump of the plasma membrane is localized in caveolae.
  2. (2008). Caveolin-3 expression and caveolae are required for isofluraneinduced cardiac protection from hypoxia and ischemia/reperfusion injury.
  3. (1998). Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain.
  4. (2006). Caveolins and the regulation of endothelial nitric oxide synthase in the heart.
  5. (1992). Localization of inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae.
  6. (1998). Modulation of the endothelial nitric-oxide synthasecaveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate.
  7. (2007). Preconditioning and postconditioning: united at reperfusion.
  8. (2006). Regional myocardial ischemia induced activation of MAPKs is associated with subcellular redistribution of caveolin and cholesterol.
  9. (2004). Role of caveolae and caveolins in health and disease.
  10. (2006). Role of lipid rafts in ceramide and nitric oxide signaling in the ischemic and preconditioned hearts.
  11. (1994). Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin.
  12. (2006). Survival kinases in ischemic preconditioning and postconditioning.
  13. (2005). The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med
  14. (2004). Tuberin is a component of lipid rafts and mediates caveolin-1 localization: role of TSC2 in post-Golgi transport.